REUTERS EVENTS: PHARMA 2026
22nd-24th 2026 CCIB | Barcelona
For 23 years, Reuters Pharma in Barcelona has been the industry's collaborative home. Our 2026 agenda has been designed from the ground up alongside your colleagues, competitors and industry experts to give you practical action, with a reimagined mix of fresh perspectives, interactive sessions, and real-world strategies.
Join 1200+ like-minded leaders and trusted partners to map the course of your next 12 months. We’re championing change, are you?
2026 confirmed speakers include:
- Lykke Hinsch Gylvin, Chief Medical Officer, Boehringer Ingelheim
- Carlos Gallardo, Chairman and CEO of Almirall and VP, EFPIA
- Dirk Hoheisel, SVP, Head of Commercial International, CSL
- Philippe Pinton, SVP, Global Research and Medical, Ferring Pharma
- Chetak Buaria, VP, Global Commercial Operations, Merck
- Maria Galindo Perez, VP, Global Head, Scientific Publications, Bayer
- Isabelle Lonjon-Domanec, MD, VP, Clinical Medical Regulatory, Novo Nordisk
- Margarita Saakova, Global Head of Launch and Strategic Planning, Alexion, AstraZeneca Rare Disease
2026 key industry themes include:
Powered by intelligent orchestration
Deliver seamless, personalised HCP journeys through AI-driven orchestration and unified data insights that drive measurable engagement and competitive differentiation
Fit for purpose data and infrastructure
Transform data fragmentation into competitive advantage by establishing secure, harmonised infrastructure that powers AI-driven insights and accelerates compliant commercial decision-making
Reimagined patient experiences
Optimise patient and experience through digital health innovation, strategic external collaboration, and co-created initiatives
Deliver value at launch
Accelerate global patient access and enhance value proposition through optimised go-to-market strategies and delivery of robust evidence packages
Interested in getting involved in Reuters Events Pharma 2026? Don’t hesitate to reach out and learn more about speaking, sponsoring and group attendance opportunities.